Literature DB >> 3037160

Disposition of enalapril and enalaprilat in renal insufficiency.

R J Fruncillo, M L Rocci, P H Vlasses, P Mojaverian, K Shepley, R A Clementi, A Oren, R D Smith, A E Till, L J Riley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3037160

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  9 in total

Review 1.  Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.

Authors:  D A Sica; T W Gehr; A Fernandez
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations.

Authors:  C Knott
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

3.  Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.

Authors:  R Greenbaum; P Zucchelli; A Caspi; H Nouriel; R Paz; S Sclarovsky; P O'Grady; K F Yee; W C Liao; B Mangold
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

4.  Modulation of gentamicin nephrotoxicity by chronic inhibition of angiotensin-I-converting enzyme in rat.

Authors:  J P Morin; N Thomas; H Toutain; H Borghi; J P Fillastre
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

Review 5.  Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.

Authors:  J Hoyer; K L Schulte; T Lenz
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

6.  Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure. Consequence of dose adjustment.

Authors:  M Neubeck; D Fliser; M Pritsch; K Weisser; M Fliser; J Nussberger; E Ritz; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.

Authors:  D A Sica; R E Cutler; R J Parmer; N F Ford
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

8.  The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.

Authors:  T W Gehr; D A Sica; D M Grasela; K L Duchin
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients.

Authors:  T W Gehr; D A Sica; D M Grasela; I Fakhry; J Davis; K L Duchin
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.